[1] Crunkhorn S.Fungal infection:Protecting from Candida albicans[J].Nat Rev Drug Discov,2016,15(9):604.
[2] Liao X,Qiu H,Li R,et al.Risk factors for fluconazole-resistant invasive candidiasis in intensive care unit patients:An analysis from the China Survey of Candidiasis study[J].J Crit Care,2015,30(5):1154.
[3] White T C,Holleman S,Dy F,et al.Resistance mechanisms in clinical isolates of Candida albicans[J].Antimicrob Agents Chemother,2002,46(6):1704-1713.
[4] Xu Y,Sheng F,Zhao J,et al.ERG11 mutations and expression of resistance genes in fluconazole-resistant Candida albicans isolates[J].Arch Microbiol,2015,197(9):1087-1093.
[5] Nobile CJ,Johnson AD.Candida albicans Biofilms and Human Disease[J].Annu Rev Microbiol,2015,69(1):71-92.
[6] Mane A,Vidhate P,Kusro C,et al.Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India[J].Mycoses,2016,59(2):93-100.
[7] Li DD.Fluconazole assists berberine to kill fluconazole-resistant Candida albicans[J].Antimicrob Agents Chemother,2013,57(12):6016-6027.
[8] Cao YY,Daib BD,Yan W,et al.In vitro activity of baicalein against Candida albicans biofilms[J].Int J Antimicrob Agents,2008,32(1):73-77.
[9] Liu W,Li LP,Zhang JD,et al.Synergistic antifungal effect of glabridin and fluconazole[J].Plos One,2014,9(7):e103442-e103442.
[10] Morais TC,Arruda BR,de Sousa Magalhães H,et al.Mangiferin ameliorates the intestinal inflammatory response and the impaired gastrointestinal motility in mouse model of postoperative ileus[J].Naunyn Schmiedebergs Arch Pharmacol,2015,388(5):531-538.
[11] Bhatia HS,Candelario-Jalil E,Oliveira A,et al.Mangiferin inhibits cyclooxygenase-2 expression and prostaglandin E 2,production in activated rat microglial cells[J].Arch Biochem Biophys,2008,477(2):253-258.
[12] Stoilova I,Ho L.Antimicrobial and antioxidant activity of the polyphenol mangiferin[J].Herba Polonica,2005,48(211):33-40.
[13] Kuykendall RJ,Lockhart SR.Microbroth dilution susceptibility testing of Candida species[J].Methods Mol Biol,2016,1356:173-181.
[14] Rex J H.Reference method for broth dilution antifungal susceptibility testing of yeasts:Third informational supplement[M].Clinical and Laboratory Standards Institute,2008.
[15] Perea S,Gonzalez G,Fothergill AW,et al.In vitro activities of terbinafine in combination with fluconazole,itraconazole,voriconazole,and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles[J].J Clin Microbiol,2002,40(5):1831-1833.
[16] Gil-Lamaignere C,Müller FM.Differential effects of the combination of caspofungin and terbinafine against Candida albicans, Candida dubliniensis,and Candida kefyr[J].Int J Antimicrob Agents,2004,23(5):520-523.
[17] Prasad R,De Wergifosse P,Goffeau A,et al.Molecular cloning and characterization of a novel gene of Candida albicans,cdr1,conferring multiple resistance to drugs and antifungals[J].Curr Genet,1995,27(4):320-329.
[18] Krishnamurthy S,Gupta V,Snehlata P,et al.Characterisation of human steroid hormone transport mediated by Cdr1p,a multidrug transporter of Candida albicans,belonging to the ATP binding cassette super family[J].FEMS Microbiol Lett,1998,158(1):69-74.
[19] Sanglard D,Ischer F,Calabrese D,et al.The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents[J].Antimicrob Agents Chemother,1999,43(11):2753-2765.
[20] Manoharlal R,Gaur NS,Morschhauser J,et al.Transcriptional activation and increased mRNA stability contribute to overexpression of CDR1 in azole-resistant Candida albicans[J].Antimicrob Agents Chemother,2008,52(4):1481-1492.